Novacare, LLC
FEI 1000220648 · 2323 S 3600 W, West Valley City, Utah, 84119, United States
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
0
Last FDA action
2023-12-01
2 years ago
FDA record
- 2023-12-01InspectionFDA inspection · Classification: No Action Indicated (NAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2018-05-09InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2017-04-10InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2016-05-06InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2015-05-27RecallRecall F-2946-2015 · Class 2 · TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with mealsSource: FDA Enforcement Reports
- 2015-03-17InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2015-03-02InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2011-12-09InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)Project area: Food Composition, Standards, Labeling and EconFDA source
- 2010-03-22InspectionFDA inspection · Classification: Official Action Indicated (OAI)Project area: Food Composition, Standards, Labeling and EconFDA source